About Cognos Therapeutics
Cognos Therapeutics is a private company based in Inglewood, California. It has reported $5,996,963 raised in nine offerings on Form D since August 2015. Its chief executive is Frank Adell.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 21, 2026 | Jul 2, 2026 | $250,000of $2.0M target | 0 | — | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Not yet | Mar 31, 2022 | $0of $2.1M target | 0 | — | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Sep 30, 2021 | Oct 12, 2021 | $55,250of $3.0M target | 3 | $18,417 | EquityRule 506(b) | Form D ↗ |
| Jun 30, 2021 | Jul 16, 2021 | $600,015fully sold | 1 | $600K | Equity, OptionsRule 506(b) | Form D ↗ |
| Dec 14, 2020 | Dec 29, 2020 | $1,000,025fully sold | 1 | $1.0M | Equity, OptionsRule 506(b) | Form D ↗ |
| May 17, 2018 | May 29, 2018 | $66,878of $1.6M target | 4 | $16,720 | Equity, OptionsRule 506(b) | Form D ↗ |
| Feb 7, 2018 | Feb 15, 2018amended May 21, 2021 | $3,816,795of $14.2M target | 117 | $32,622 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Apr 8, 2016 | Apr 20, 2016 | $48,000of $880K target | 2 | $24,000 | Equity, OptionsRule 506(b) | Form D ↗ |
| Sep 10, 2015 | Aug 24, 2015amended Dec 10, 2015 | $160,000of $45.3M target | 5 | $32,000 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, nine offerings | $5,996,963 | |||||
The filing for the offering first filed Jul 2, 2026 reports amount sold with no investors. Figures are shown as filed.
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Cognos Therapeutics's Form D filed Jul 2, 2026.
Earlier filings also listed Josh Shachar (director, last listed Mar 2022), Winston Wu (director, last listed Jul 2021), Richard Lerner (director, last listed Jul 2021), Roger Kornberg, Ph.D. (director, last listed Dec 2020), Roger Kornberg (director, last listed May 2018), Ronald Solar (director, last listed Apr 2016) and Frank (aka Farokh) Adell (aka Adelzadeh) (president and director, last listed Apr 2016).